Hormonal Comparison

Sermorelin vs Tesamorelin

Comparison of two GHRH analogs - one discontinued (sermorelin) and one FDA-approved (tesamorelin).

Last updated: January 19, 2026

Sermorelin

Moderate Evidence
View full dossier

Tesamorelin

High Evidence
View full dossier

Overview

Both sermorelin and tesamorelin are GHRH analogs that stimulate endogenous growth hormone release. Tesamorelin remains FDA-approved while sermorelin was discontinued.

Status Comparison

AspectSermorelinTesamorelin
FDA StatusWas approved; discontinuedCurrently approved
Brand NameGeref (discontinued)Egrifta
AvailabilityCompounding onlyPrescription

Approved Indications

PeptideIndicationPopulation
SermorelinWas: Pediatric GH deficiencyChildren
TesamorelinHIV lipodystrophyAdults with HIV

Mechanism

Both work identically:

  • Bind GHRH receptors on pituitary
  • Stimulate endogenous GH release
  • Maintain physiologic pulsatile pattern
  • Require functional pituitary

Pharmacokinetics

ParameterSermorelinTesamorelin
Half-life10-20 min26-38 min
AdministrationDaily SCDaily SC
MetabolismProteolyticProteolytic

Clinical Evidence

AspectSermorelinTesamorelin
Phase 3 DataYes (historical)Yes
Long-term DataLimitedExtension studies
VAT ReductionNot studied15% reduction

Why Sermorelin Was Discontinued

Sermorelin (Geref) was discontinued for commercial reasons, not safety or efficacy:

  • Low sales volume
  • Manufacturing costs
  • Business decision by manufacturer

Why Choose One Over Other

If you need…Consider
FDA-approved optionTesamorelin
HIV lipodystrophyTesamorelin
GH deficiency testingNeither (other tests available)
Off-label GH stimulationDiscuss with physician

Summary

  • Tesamorelin is the only GHRH analog currently FDA-approved
  • Sermorelin has historical approval but is no longer commercially available
  • Both preserve physiologic GH patterns
  • Tesamorelin has specific evidence for reducing visceral fat in HIV

This comparison is for educational purposes only. Tesamorelin requires a prescription and is approved for specific indications.

Stay Updated on Peptide Comparisons

Get notified when we publish new comparison dossiers and evidence reviews.

No spam. Unsubscribe anytime.

Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.